ChemicalBook > CAS DataBase List > Banoxantrone (dihydrochloride)

Banoxantrone (dihydrochloride)

Product Name
Banoxantrone (dihydrochloride)
CAS No.
252979-56-9
Chemical Name
Banoxantrone (dihydrochloride)
Synonyms
Banoxantrone 2HCl;AQ4N dihydrochloride;Banoxantrone dihydrochloride >=98% (HPLC);Banoxantrone dihydrochloride, 10 mM in DMSO;Banoxantrone dihydrochloride (AQ4N dihydrochloride);Banoxantrone dihydrochloride (AQ4N), Topoisomerase II inhibitor;1,4-Bis[[2-(dimethyloxidoamino)ethyl]amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride;9,10-Anthracenedione, 1,4-bis[[2-(dimethyloxidoamino)ethyl]amino]-5,8-dihydroxy-, hydrochloride;2,2'-((5,8-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-1,4-diyl)bis(azanediyl))bis(N,N-dimethylethanamine oxide) dihydrochloride;2,2'-((5,8-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-1,4-diyl)bis(azanediyl))bis(N,N-dimethylethanamine oxide) dihydrochloride
CBNumber
CB73339609
Molecular Formula
C22H29ClN4O6
Formula Weight
480.95
MOL File
252979-56-9.mol
More
Less

Banoxantrone (dihydrochloride) Property

storage temp. 
Store at -20°C, protect from light, stored under nitrogen
solubility 
Soluble to 50 mM in water and to 25 mM in DMSO
form 
Solid
color 
Blue to dark blue
Water Solubility 
Water : 25 mg/mL (48.32 mM)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

H350May cause cancer

Precautionary statements

P201Obtain special instructions before use.

P202Do not handle until all safety precautions have been read and understood.

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML1854
Product name
Banoxantrone dihydrochloride
Purity
≥98% (HPLC)
Packaging
5 mg
Price
$135
Updated
2025/07/31
Sigma-Aldrich
Product number
SML1854
Product name
Banoxantrone dihydrochloride
Purity
≥98% (HPLC)
Packaging
25 mg
Price
$437
Updated
2025/07/31
TRC
Product number
B129285
Product name
BanoxantroneDihydrochloride
Packaging
2.5mg
Price
$250
Updated
2021/12/16
ChemScene
Product number
CS-6986
Product name
Banoxantronedihydrochloride
Purity
99.17%
Packaging
5mg
Price
$96
Updated
2021/12/16
ChemScene
Product number
CS-6986
Product name
Banoxantronedihydrochloride
Purity
99.17%
Packaging
10mg
Price
$168
Updated
2021/12/16
More
Less

Banoxantrone (dihydrochloride) Chemical Properties,Usage,Production

Uses

Banoxantrone (AQ4N) is a hypoxia-activated prodrug of topoisomerase II inhibitor AQ4 (Bioreductive AQ4 precursor). studies have shown that its has also exhibited anti-tumor efficacy in vivo when combined with oxic cell cytotoxins.

Biological Activity

Banoxantrone (AQ4N) is a hypoxia-activated prodrug of topoisomerase II inhibitor AQ4 (Bioreductive AQ4 precursor).', 'Banoxantrone dihydrochloride enhances the anti-tumor effect caused by radiation.

in vivo

Banoxantrone (200 mg/kg) significantly enhances the tumor growth delay caused by radiation. This occurred when radiation is administered both as a single dose (12 Gy) and in a multifraction regimen (5x3 Gy). A study of the scheduling of Banoxantrone (AQ4N) administration shows that there is a very long time period over which a maximal effect can be elicited (drug given 4 days before to 6 h after radiation). These results suggest that Banoxantrone has significant potential as a bioreductive drug[1]. The activation of banoxantrone cytotoxicity in vivo requires tumor hypoxia that is more extensive or prolonged than can readily be achieved by vasodilation or by antiangiogenic drug treatment[2]. Incorporation of banoxantrone into conventional chemoradiation protocols therefore targets both oxygenated and hypoxic regions of tumors, and potentially will increase the effectiveness of therapy. A single dose of 60 mg/kg banoxantrone enhances the response of RT112 (bladder) and Calu-6 (lung) xenografts to treatment with cisplatin and radiation therapy. Banoxantrone will increase the efficacy of chemoradiotherapy in preclinical models[3].

IC 50

Topoisomerase II

storage

Store at +4°C

Banoxantrone (dihydrochloride) Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Banoxantrone (dihydrochloride) Suppliers

Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Fax
+86-25-83453306
Email
info@chemlin.com.cn
Country
China
ProdList
16077
Advantage
64
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Country
United States
ProdList
12952
Advantage
65
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
Shanghai Macklin Biochemical Co.,Ltd.
Tel
15221275939
Fax
021-50706099
Email
shenlinxing@macklin.cn
Country
China
ProdList
15873
Advantage
55
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
Beijing OKA biological technology co., LTD
Tel
010-62971590 18548936886
Fax
010-62340519
Email
3462612863@qq.com
Country
China
ProdList
10063
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11218
Advantage
58
Shanghai hongqu biomedical technology co. LTD
Tel
88888888888
Email
hongquchem@qq.com
Country
China
ProdList
5132
Advantage
58

252979-56-9, Banoxantrone (dihydrochloride)Related Search:


  • Banoxantrone 2HCl
  • 1,4-Bis[[2-(dimethyloxidoamino)ethyl]amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride
  • AQ4N dihydrochloride
  • Banoxantrone dihydrochloride >=98% (HPLC)
  • 2,2'-((5,8-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-1,4-diyl)bis(azanediyl))bis(N,N-dimethylethanamine oxide) dihydrochloride , Banoxantrone 2HCl
  • 2,2'-((5,8-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-1,4-diyl)bis(azanediyl))bis(N,N-dimethylethanamine oxide) dihydrochloride
  • Banoxantrone dihydrochloride (AQ4N), Topoisomerase II inhibitor
  • Banoxantrone dihydrochloride, 10 mM in DMSO
  • 2,2'-((5,8-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-1,4-diyl)bis(azanediyl))bis(N,N-dimethylethanamine oxide) dihydrochloride
  • Banoxantrone dihydrochloride (AQ4N dihydrochloride)
  • 9,10-Anthracenedione, 1,4-bis[[2-(dimethyloxidoamino)ethyl]amino]-5,8-dihydroxy-, hydrochloride
  • 252979-56-9